Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myositis overlap syndromes.

Y Ioannou1, S Sultan, D A Isenberg

  • 1Centre for Rheumatology, Department of Medicine, University College London, UK.

Current Opinion in Rheumatology
|November 7, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.

Lupus·2013
Same author

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature.

Lupus·2013
Same author

Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Lupus·2013
Same author

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.

Lupus·2013
Same author

Rheumatological manifestations occurring in patients with diabetes mellitus.

Scandinavian journal of rheumatology·2012
Same author

What constitutes uncertainty in systemic lupus erythematosus and rheumatoid arthritis?

Psychology & health·2012
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Myositis-overlap syndromes involve various autoimmune conditions linked to specific autoantibodies. Research clarifies their causes and guides treatment for conditions like mixed connective tissue disease and myositis-scleroderma overlap.

Area of Science:

  • Rheumatology
  • Immunology
  • Genetics

Background:

  • Myositis-overlap syndromes present diverse clinical features often associated with specific autoantibodies.
  • Understanding immunogenetic and environmental factors is crucial for autoimmune disease etiopathogenesis.
  • Autoantibodies like anti-snU1 RNP, anti-PM-Scl, and anti-tRNA synthetase antibodies are key diagnostic and prognostic markers.

Purpose of the Study:

  • To explore the clinical spectrum and diagnostic challenges of myositis-overlap syndromes.
  • To elucidate the role of specific autoantibodies in the pathogenesis and prognosis of these syndromes.
  • To differentiate between distinct disease entities and undifferentiated overlap syndromes based on autoantibody profiles.

Main Methods:

  • Review of clinical and laboratory findings in patients with myositis-overlap syndromes.

Related Experiment Videos

  • Analysis of autoantibody profiles, including anti-snU1 RNP, anti-PM-Scl, and anti-tRNA synthetase antibodies (e.g., anti-Jo1).
  • Correlation of autoantibody status with clinical manifestations, disease course, and treatment response.

    • Main Results:

    • Anti-snU1 RNP antibodies are associated with features of undifferentiated autoimmune rheumatic/overlap syndromes, challenging single disease classification.
    • Anti-PM-Scl antibodies indicate myositis-scleroderma overlap, typically with a favorable prognosis and response to minimal immunosuppression.
    • Anti-tRNA synthetase antibodies, particularly anti-Jo1, are linked to severe interstitial lung disease and a poorer prognosis, requiring aggressive therapy.

    Conclusions:

    • Myositis-overlap syndromes represent a spectrum of autoimmune diseases defined by distinct autoantibody profiles.
    • Autoantibody analysis is essential for accurate diagnosis, prognosis prediction, and guiding therapeutic strategies in these complex conditions.
    • Further research is needed to fully delineate the distinct disease entities within the myositis-overlap syndrome classification.